Literature DB >> 16717132

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.

Nasser Semmo, Michaela Lucas, George Krashias, Georg Lauer, Helen Chapel, Paul Klenerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16717132     DOI： 10.1182/blood-2005-11-4522

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

Review 1.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.

Authors:  Theo Heller; Jens Martin Werner; Fareed Rahman; Eishiro Mizukoshi; Yuji Sobao; Ann Marie Gordon; Arlene Sheets; Averell H Sherker; Ellen Kessler; Kathleen S Bean; Steven K Herrine; M'lou Stevens; James Schmitt; Barbara Rehermann
Journal:  J Infect Dis       Date:  2013-06-24       Impact factor: 5.226

3.  Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice.

Authors:  Santa Olivera; Angel Perez; Viviana Falcon; Dioslaida Urquiza; Dagmara Pichardo; Gillian Martinez-Donato
Journal:  Arch Virol       Date:  2020-02-03       Impact factor: 2.574

4.  Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

Authors:  Dorothea Bankwitz; Eike Steinmann; Julia Bitzegeio; Sandra Ciesek; Martina Friesland; Eva Herrmann; Mirjam B Zeisel; Thomas F Baumert; Zhen-yong Keck; Steven K H Foung; Eve-Isabelle Pécheur; Thomas Pietschmann
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.

Authors:  Sukanya Raghuraman; Heiyoung Park; William O Osburn; Emily Winkelstein; Brian R Edlin; Barbara Rehermann
Journal:  J Infect Dis       Date:  2012-01-31       Impact factor: 5.226

Review 6.  Will there be a vaccine to prevent HCV infection?

Authors:  Jonathan R Honegger; Yan Zhou; Christopher M Walker
Journal:  Semin Liver Dis       Date:  2014-04-29       Impact factor: 6.115

7.  High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.

Authors:  Carmen E Gómez; Beatriz Perdiguero; María Victoria Cepeda; Lidia Mingorance; Juan García-Arriaza; Andrea Vandermeeren; Carlos Óscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 8.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.

Authors:  Jens Martin Werner; Theo Heller; Ann Marie Gordon; Arlene Sheets; Averell H Sherker; Ellen Kessler; Kathleen S Bean; M'Lou Stevens; James Schmitt; Barbara Rehermann
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

Review 10.  Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.

Authors:  Ulrich Spengler; Hans Dieter Nischalke; Jacob Nattermann; Christian P Strassburg
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.